Coherus Biosciences Inc (NASDAQ:CHRS)

22.44
Data as of Jan 30
 -0.56 / -2.43%
Today’s Change
12.27
Today|||52-Week Range
24.46
+37.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

--

--

--
Revenue and IncomeNet Revenues2.8M------
 
 
Depreciation And Amortization404.0K------
 
 
 
Operating ExpensesGross Income----------
General Expenses38.3M------
 
 
Research And Development31.3M------
 
 
Total Operating Expenses38.7M------
 
 
 
Non-Operating ExpensesOperating Income-36.0M------
 
 
Interest Expense On Debt5.3M------
 
 
Other Expenses-12.3M------
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.6M------
 
 
Net Income-53.6M------
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.6M------
 
 
Shares To Calculate EPS Diluted5.6M------
 
 
 
Earnings Per ShareEPS-$9.66------
 
 
EPS Diluted-$9.66------
 
 
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.